Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising from the principal cells of the collecting duct. One third of cases present with metastatic disease, but many present in a manner similar to conventional RCC or urothelial carcinoma (UC). We discuss a case of CDC which presented as a small mass at the cortico-medullary junction, and was discovered at robotic partial nephrectomy (RPN) to be grossly involving the collecting system. A 62-year-old man presented with a small renal mass suspicious for RCC, which was found on computed tomography (CT) after an episode of gross hematuria. After thorough workup, RPN was attempted; however, intraoperatively the mass was found to be involving the coll...
Collecting duct carcinoma (CDC) is a rare, highly aggressive malignant neoplasm that arises from the...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising ...
A nephrectomy specimen was sent to the laboratory for end stage renal disease secondary to nephrolit...
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma (RCC) of collec...
ABSTRACTCollecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. T...
The modern era has brought an appreciation that renal cell carcinoma (RCC) includes diverse subtypes...
To study the clinicopathologic characteristics of renal collecting duct carcinoma (CDC).A retrospect...
Item does not contain fulltextOBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but...
AbstractCollecting duct carcinoma (CDC), is a rare and aggressive form of renal cell carcinoma (RCC)...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Purpose: Collecting duct carcinoma of the kidney (CDC) is an aggressive subtype of renal cell carcin...
OBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but reportedly aggressive histolo...
Collecting duct carcinoma (CDC) is a rare, highly aggressive malignant neoplasm that arises from the...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising ...
A nephrectomy specimen was sent to the laboratory for end stage renal disease secondary to nephrolit...
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma (RCC) of collec...
ABSTRACTCollecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. T...
The modern era has brought an appreciation that renal cell carcinoma (RCC) includes diverse subtypes...
To study the clinicopathologic characteristics of renal collecting duct carcinoma (CDC).A retrospect...
Item does not contain fulltextOBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but...
AbstractCollecting duct carcinoma (CDC), is a rare and aggressive form of renal cell carcinoma (RCC)...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Purpose: Collecting duct carcinoma of the kidney (CDC) is an aggressive subtype of renal cell carcin...
OBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but reportedly aggressive histolo...
Collecting duct carcinoma (CDC) is a rare, highly aggressive malignant neoplasm that arises from the...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...